Delivery Order SPE2DB22D3501-SPE2DB24FUN18
- Not listed
- The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to support military treatment programs and facilities. The contract has a potential value of $3,713.52 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which is...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML at a firm fixed price of $1,856.75. This delivery order contract has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to deliver...
- This firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has a potential value of $3,713.52. The order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $138,762 firm fixed price delivery order contract to provide TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML syringes. The contract has a completion date of May 23, 2023. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to various U.S. government agencies, including the Department of Defense. This award was not set aside and is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. The $228,578.75 contract has an April 3, 2023 completion date and was awarded on March 31, 2023. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies,...
- This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $11,140.50 order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of March 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor, delivering this product to support...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,970.88 contract is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to be completed by March 5, 2024. Amerisourcebergen Drug Corp has received numerous prior contract awards from DLA Troop Support Medical to supply pharmaceuticals,...
- The Defense Logistics Agency (DLA) awarded a $1,114.08 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. This delivery order was not set aside and is part of Amerisourcebergen's existing indefinite delivery contract to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. Amerisourcebergen, a leading global pharmaceutical distributor, has a history of...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $3,713.52 and a performance period through May 2, 2024. The delivery order was not set aside for any specific business...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The $3,700.32 firm fixed price contract is for the supply of TICOVAC 2.4 MCG/0.5 ML syringes. This delivery order is issued under Amerisourcebergen Drug Corp's $999,999,999.00 indefinite delivery contract with DLA, which serves as the primary vehicle for the company to provide...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUN18Delivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. The order, valued at $1,856.75, has a completion date of March 4, 2024 and was awarded on February 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to various U.S. government agencies, particularly the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 2/9/24 |